NARA Discovery
Article Details
← Back to Search Results
Journal Article

Genetic variability and structure of Canadian populations of Chondrostereum purpureum , a potential biophytocide

Lyne Gosselin; Robert Jobidon; Louis Bernier
Molecular Ecology · Vol. 8, Issue 1 · pp. 113-122 · 1999

Abstract

Genetic diversity was studied in four Canadian ecological populations, each corresponding to a Canadian ecozone, of Chondrostereum purpureum , including 93 isolates of various host origin. Pseudo‐allelic frequencies were estimated at each of 22 putative RAPD loci by scoring for presence or absence of amplicons in haploid mycelial cultures. The analysis of the hierarchical population structure did not reveal any trend with regard to ecological or host origin. Total gene diversity ( H T † = 0.288) was mostly attributable to diversity within populations ( H S † = 0.269). In addition, the AMOVA analysis detected most of the molecular variability within subpopulations (89.3%; P P = 0.001) proportion of the gene diversity was found among subpopulations, within ecozones. The results indicate that C. purpureum is a highly heterogeneous pathogen with a continuously distributed population across Canada ( G ST † = 0.048), and underscore the importance of considering the population structure in the process of its registration as a microbial control agent. A genotype isolated in either central or eastern Canada (ecozones 2, 4 and 5 populations) and selected for its potential as a biophytocide should be considered indigenous in any of these regions of intended use.

Bibliographic Information

JournalMolecular Ecology
PublisherWiley
Publication Date1999-01-09
Publication Year1999
Volume8
Issue1
Pages113-122
Document TypeJournal Article
Print ISSN0962-1083
eISSN1365-294X
DOI10.1046/j.1365-294x.1999.00543.x
SubjectEcology & Organismal Biology

Access Information

NARA Access Coverage1997-01-01~Current
Journal Homepagehttps://onlinelibrary.wiley.com/loi/1365294X
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.